1. Search Result
Search Result
Results for "

SMARCB1

" in MedChemExpress (MCE) Product Catalog:

7

Inhibitors & Agonists

3

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-145925B
    CFT8634
    1 Publications Verification

    PROTACs Epigenetic Reader Domain Cancer
    CFT8634 is an orally bioavailable PROTAC BRD9 targeted degrader based on the E3 ubiquitin ligase CRBN mechanism. CFT8634 can be used for the study of synovial sarcoma and SMARCB1-deficient solid tumors (Pink: BRD9 ligand (HY-169988); Blue: E3 ligase ligand (HY-169989); Black: linker (HY-169991). CFT8634 is a heterobifunctional molecule that binds to BRD9 at one end and recruits CRBN at the other end, which can inhibit the growth of tumor cells that depend on BRD9. CFT8634 can be used for the study of SMARCB1-related cancers (such as synovial sarcoma and malignant rhabdoid tumor) [1] .
    CFT8634
  • HY-131246

    Histone Methyltransferase Cancer
    DM-01 is a powerful and selective EZH2 inhibitor for the research of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and SNF5/INI-1/SMARCB1 genetically defined solid tumors [1].
    DM-01
  • HY-13803
    Tazemetostat
    70+ Cited Publications

    EPZ-6438; E-7438

    Histone Methyltransferase Apoptosis Cancer
    Tazemetostat (EPZ-6438) is a potent, selective and orally available EZH2 inhibitor. Tazemetostat inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with a Ki value of 2.5 nM. Tazemetostat inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat inhibits rat EZH2 with an IC50 of 4 nM. Tazemetostat also inhibits EZH1 with an IC50 of 392 nM. Tazemetostat induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells [1].
    Tazemetostat
  • HY-13803R

    EPZ-6438 (Standard); E-7438 (Standard)

    Reference Standards Histone Methyltransferase Apoptosis Cancer
    Tazemetostat (Standard) is the analytical standard of Tazemetostat. This product is intended for research and analytical applications. Tazemetostat (EPZ-6438) is a potent, selective and orally available EZH2 inhibitor. Tazemetostat inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with a Ki value of 2.5 nM. Tazemetostat inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat inhibits rat EZH2 with an IC50 of 4 nM. Tazemetostat also inhibits EZH1 with an IC50 of 392 nM. Tazemetostat induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells [1].
    Tazemetostat (Standard)
  • HY-RS17520

    Small Interfering RNA (siRNA) Others

    Smarcb1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Smarcb1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Smarcb1 Mouse Pre-designed siRNA Set A
    Smarcb1 Mouse Pre-designed siRNA Set A
  • HY-RS23976

    Small Interfering RNA (siRNA) Others

    Smarcb1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Smarcb1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Smarcb1 Rat Pre-designed siRNA Set A
    Smarcb1 Rat Pre-designed siRNA Set A
  • HY-RS13409

    Small Interfering RNA (siRNA) Others

    SMARCB1 Human Pre-designed siRNA Set A contains three designed siRNAs for SMARCB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    SMARCB1 Human Pre-designed siRNA Set A
    SMARCB1 Human Pre-designed siRNA Set A

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: